Literature DB >> 3742493

Phase II trial of mitoxantrone in advanced primary liver cancer: a Cancer and Leukemia Group B Study.

R B Davis, D A Van Echo, L A Leone, E S Henderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3742493

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  4 in total

Review 1.  Metronomic chemotherapy: possible clinical application in advanced hepatocellular carcinoma.

Authors:  Takuji Torimura; Hideki Iwamoto; Toru Nakamura; Hironori Koga; Takato Ueno; Robert S Kerbel; Michio Sata
Journal:  Transl Oncol       Date:  2013-10-01       Impact factor: 4.243

Review 2.  Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors:  D Faulds; J A Balfour; P Chrisp; H D Langtry
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

3.  Phase II study of mitoxantrone in unresectable primary hepatocellular carcinoma following hepatitis B infection.

Authors:  K H Lai; Y T Tsai; S D Lee; W W Ng; H C Teng; T N Tam; G H Lo; H C Lin; H J Lin; J C Wu
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 4.  Dysregulation of the Ubiquitin Proteasome System in Human Malignancies: A Window for Therapeutic Intervention.

Authors:  Chee Wai Fhu; Azhar Ali
Journal:  Cancers (Basel)       Date:  2021-03-25       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.